4.4 Review

A comprehensive review of genetics and genetic testing in azoospermia

期刊

CLINICS
卷 68, 期 -, 页码 39-60

出版社

HOSPITAL CLINICAS, UNIV SAO PAULO
DOI: 10.6061/clinics/2013(Sup01)06

关键词

Azoospermia; Male Infertility; Genetic Testing; Genetic Diseases; Klinefelter Syndrome; Y Chromosome

向作者/读者索取更多资源

Azoospermia due to obstructive and non-obstructive mechanisms is a common manifestation of male infertility accounting for 10-15% of such cases. Known genetic factors are responsible for approximately 1/3 of cases of azoospermia. Nonetheless, at least 40% of cases are currently categorized as idiopathic and may be linked to unknown genetic abnormalities. It is recommended that various genetic screening tests are performed in azoospermic men, given that their results may play vital role in not only identifying the etiology but also in preventing the iatrogenic transmission of genetic defects to offspring via advanced assisted conception techniques. In the present review, we examine the current genetic information associated with azoospermia based on results from search engines, such as PUBMED, OVID, SCIENCE DIRECT and SCOPUS. We also present a critical appraisal of use of genetic testing in this subset of infertile patients.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.4
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Review Genetics & Heredity

Risk of genetic and epigenetic alteration in children conceived following ART: Is it time to return to nature whenever possible?

Romualdo Sciorio, Luca Tramontano, Erika Rapalini, Serena Bellaminutti, Francesco M. Bulletti, Antonio D'Amato, Claudio Manna, Antonio Palagiano, Carlo Bulletti, Sandro C. Esteves

Summary: Assisted reproductive technology may have an impact on the epigenome of embryos, but the extent of this influence is not yet clear. Concerns have been raised about the increased occurrence of epigenetic anomalies and imprinting following assisted reproductive technology. The periconceptional period is particularly vulnerable to environmental conditions, and various factors in assisted reproductive technology have the potential to disrupt epigenetic regulation.

CLINICAL GENETICS (2023)

Article Obstetrics & Gynecology

Male infertility and gonadotropin treatment: What can we learn from real-world data?

Sandro C. Esteves, Arnold P. P. Achermann, Manuela Simoni, Daniele Santi, Livio Casarini

Summary: Evidence-based gonadotropin therapy effectively restores spermatogenesis and fertility in male infertility disorders associated with hypogonadotropic hypogonadism. However, its use to improve fertility in men with idiopathic oligozoospermia or nonobstructive azoospermia remains controversial. Real-world data research suggests that gonadotropin therapy may be more effective in managing selected male infertility patients, with potential gains for all parties involved.

BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY (2023)

Article Obstetrics & Gynecology

Treatment algorithms for high responders: What we can learn from randomized controlled trials, real-world data and models

Panagiotis Drakopoulos, Yakoub Khalaf, Sandro C. Esteves, Nikolaos P. Polyzos, Sesh K. Sunkara, Daniel Shapiro, Botros Rizk, Hong Ye, Michael Costello, Yulia Koloda, Bruno Salle, Monica Lispi, Thomas D'Hooghe, Antonio La Marca

Summary: A high ovarian response refers to a greater number of follicles and/or oocytes compared to a normal response. It can be diagnosed before oocyte pick-up when there are >18-20 follicles ≥11-12 mm, or after oocyte pick-up when >18-20 oocytes have been retrieved. Women with a high response are at high risk of ovarian hyperstimulation syndrome (OHSS). Appropriate management strategies, such as individualized gonadotropin dosing, monitoring, and choice of protocols, can greatly reduce the risk of high response.

BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY (2023)

Letter Obstetrics & Gynecology

Reply of the authors: Applying reasonable methodological and statistical methods in clinical data analysis

Sandro C. Esteves, Jose F. Carvalho

FERTILITY AND STERILITY (2023)

Article Obstetrics & Gynecology

A drop in serum progesterone from oocyte pick-up+3 days to+5 days in fresh blastocyst transfer, using hCG-trigger and standard luteal support, is associated with lower ongoing pregnancy rates

Esra Uyanik, Sezcan Mumusoglu, Mehtap Polat, Irem Yarali Ozbek, Sandro C. Esteves, Peter Humaidan, Hakan Yarali

Summary: A drop in serum P-4 level from oocyte pick-up (OPU) + 3 days to OPU + 5 days may result in a decrease in ongoing pregnancy rates. This decrease may be associated with lower initial pregnancy rates rather than increased overall pregnancy loss rates.

HUMAN REPRODUCTION (2023)

Review Andrology

Surgically retrieved spermatozoa for ICSI cycles in non-azoospermic males with high sperm DNA fragmentation in semen

Sandro C. Esteves, Igor Coimbra, Jorge Hallak

Summary: Intracytoplasmic sperm injection (ICSI) using surgically retrieved spermatozoa outside the classic context of azoospermia has shown improvement in pregnancy and miscarriage rates, possibly due to lower levels of DNA damage in testicular spermatozoa compared to ejaculated spermatozoa. However, data is limited and mainly focuses on males with confirmed sperm DNA damage. Further research is needed to assess the health of ICSI offspring resulting from surgically retrieved spermatozoa of non-azoospermic males. A comprehensive evaluation and treatment of underlying male infertility factors contributing to sperm DNA damage is crucial for safer and more effective ICSI utilization.

ANDROLOGY (2023)

Article Obstetrics & Gynecology

The Fischer protocol for assisted reproductive technology treatment: Real-world data experience comparing elective single versus double embryo transfer with or without comprehensive chromosome screening

Vera Baukloh, Rita C. S. Figueira, Fabiola C. Bento, Fabiana Y. Nakano, Silval F. C. Zabaglia, Sandro C. Esteves, Robert Fischer

Summary: This report presents real-life data from two clinics using the Fischer protocol for cycle programming in patients undergoing assisted reproductive technology (ART) treatment. The study found that ovarian stimulation using the Fischer protocol provides consistent and optimal ART outcomes. However, high rates of multiple implantation were observed, especially when transferring two embryos to patients aged over 39 years. Live birth rates were higher after comprehensive chromosome screening (CCS) compared to untested embryos. Therefore, the recommendation is to implement a single embryo transfer policy, particularly for women under 34 years of age with favorable ART treatment conditions.

BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY (2023)

Article Obstetrics & Gynecology

Total fertilization failure after ICSI: insights into pathophysiology, diagnosis, and management through artificial oocyte activation

Gerard Campos, Romualdo Sciorio, Sandro C. Esteves

Summary: Total fertilization failure is the failure of all metaphase II oocytes to fertilize in assisted reproduction cycles. Oocyte activation deficiency is the main cause of fertilization failure, attributed to sperm or oocyte issues. Diagnostic testing and artificial oocyte activation treatments are crucial for overcoming fertilization failure.

HUMAN REPRODUCTION UPDATE (2023)

Article Reproductive Biology

Exploring the potential impact of human papillomavirus on infertility and assisted reproductive technology outcomes

Luca Tramontano, Romualdo Sciorio, Serena Bellaminutti, Sandro C. Esteves, Patrick Petignat

Summary: Human papillomavirus (HPV) is a common sexually transmitted disease associated with cancer and reproductive health issues. The influence of HPV on assisted reproductive technology (ART) outcomes is not well understood, leading to a need for HPV testing in couples undergoing infertility treatments. Infertile men with seminal HPV infection may experience compromised sperm quality and reproductive function, highlighting the importance of investigating the correlation between HPV and ART outcomes. Understanding the potential detrimental effects of HPV on ART outcomes may have significant implications for infertility management.

REPRODUCTIVE BIOLOGY (2023)

Editorial Material Urology & Nephrology

Introducing the IBJU patient corner new section

Sandro C. Esteves

INTERNATIONAL BRAZ J UROL (2023)

Article Medicine, General & Internal

Male infertility

Michael L. Eisenberg, Sandro C. Esteves, Dolores J. Lamb, James M. Hotaling, Aleksander Giwercman, Kathleen Hwang, Yu-Sheng Cheng

Summary: Clinical infertility refers to the inability of a couple to conceive after 12 months of trying. Male factors contribute to 30-50% of infertility cases. Infertility can be caused by testicular dysfunction, endocrinopathies, lifestyle factors, congenital anatomical factors, gonadotoxic exposures, and aging among others. The evaluation of male infertility includes history taking, physical examination, and laboratory testing. Treatments include lifestyle optimization, medical therapy, and surgical interventions.

NATURE REVIEWS DISEASE PRIMERS (2023)

Article Obstetrics & Gynecology

Unraveling the Impact of Sperm DNA Fragmentation on Reproductive Outcomes

Jeanett L. M. Nielsen, Ahmad Majzoub, Sandro Esteves, Peter Humaidan

Summary: In recent years, there has been an increasing interest in identifying subcellular causes of male infertility, with a focus on sperm DNA fragmentation (SDF) research. SDF can occur during spermatogenesis or as sperm transit through the genital tract, negatively impacting male reproductive potential. Studies have found that DNA damage is associated with sperm morphological and functional abnormalities, ultimately affecting natural conception and assisted reproductive technology outcomes.

SEMINARS IN REPRODUCTIVE MEDICINE (2023)

Review Endocrinology & Metabolism

COVID-19 and its treatments: lights and shadows on testicular function

Francesco Pallotti, Sandro C. Esteves, Fabiana Faja, Alessandra Buonacquisto, Anna Chiara Conflitti, Maria Neve Hirsch, Andrea Lenzi, Donatella Paoli, Francesco Lombardo

Summary: COVID-19 may have indirect effects on male reproductive system, but there is limited evidence to support this. Despite the low quality of available evidence, careful andrological evaluation and follow-up for men recovering from COVID-19 are still necessary.

ENDOCRINE (2023)

Meeting Abstract Obstetrics & Gynecology

CHALLENGES AND POTENTIAL PRACTICE GAPS FACED BY HEALTHCARE PROFESSIONALS INVESTIGATING MALE INFERTILITY: A PATIENT-INFORMED EDUCATIONAL STUDY IN EIGHT COUNTRIES

Markus S. Kupka, Monica Augustyniak, Sandro C. Esteves, Giovanni Coticchio, Anita Fincham, Patrice Lazure, Sophie Peloquin

FERTILITY AND STERILITY (2022)

暂无数据